Search all trials

Find therapies in clinical trials near you – page 89

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Microsatellite instability cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drugNo placebo

Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Belimumab

Contact Research Centre

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting

Registered drugNo placebo

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Registered drugNo placebo

Greece

Participants:0–17 years
Substances:Alemtuzumab

Contact Research Centre

Waldenstrom's macroglobulinaemia

Not recruiting

Registered drugNo placebo

Study on Carfilzomib and Ibrutinib for Patients with Waldenström’s Macroglobulinemia

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Small cell lung cancer recurrent

Not recruiting

Registered drugNo placebo

Study of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Siltuximab

Contact Research Centre

Plasma cell myeloma

Not recruiting

InvestigationalNo placebo

Study on Iberdomide for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem Cell Transplantation

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Iberdomide

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

InvestigationalNo placebo

Study of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Isatuximab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study of isatuximab, belantamab mafodotin and dexamethasone combination for patients with relapsed or refractory multiple myeloma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Belantamab Mafodotin

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study of Isatuximab with Lenalidomide and Dexamethasone for Elderly Patients (70+) with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Greece

Participants:65+ years
Substances:Isatuximab

Contact Research Centre

Neurodermatitis

Not recruiting

Investigational

Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Rocatinlimab

Contact Research Centre

Find therapies in clinical trials near you – page 89

1 084 trials match your criteria

Microsatellite instability cancer+1

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Non-small cell lung cancer

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Systemic lupus erythematosus

Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Waldenstrom's macroglobulinaemia

Study on Carfilzomib and Ibrutinib for Patients with Waldenström’s Macroglobulinemia

Small cell lung cancer recurrent

Study of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments

Plasma cell myeloma

Study on Iberdomide for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem Cell Transplantation

Plasma cell myeloma refractory

Study of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy

Plasma cell myeloma

Study Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Plasma cell myeloma refractory

Study of isatuximab, belantamab mafodotin and dexamethasone combination for patients with relapsed or refractory multiple myeloma

Plasma cell myeloma

Study of Isatuximab with Lenalidomide and Dexamethasone for Elderly Patients (70+) with Newly Diagnosed Multiple Myeloma

Neurodermatitis

Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.